Abstract
This chapter contains a collection of interviews with immunologist colleagues who have, like myself, been involved in or exposed to the idiotypic network theory (INT) during a significant part of their active scientific career. Some of the key individuals in idiotype research have passed away, but those still living have been approached and many of them agreed to participate. In order to maintain a comparable structure, interviewees were sent a list of 15 questions well before the interview:
-
Q1.
What was your attitude to the INT in the beginning, say 1975–78?
-
Q2.
Have you been involved in idiotypic research prior to INT? If yes, what particular aspect?
-
Q3.
Did you get involved in idiotypic research as a result of INT? If yes, what particular aspect?
-
Q4.
Did you reject INT then? If yes, why?
-
Q5.
What are your views now about the former controversy about the Ig/non-Ig nature of the TCR?
-
Q6.
What do you think now about the former research on suppressor T cells?
-
Q7.
What about the inducer/transducer/effector concepts on helper/suppressor T cell circuits?
-
Q8.
What do you think about the former results on soluble helper and suppressor factors?
-
Q9.
Do you think INT had a stimulating/inhibitory influence in immunological research?
-
Q10.
Do you think that some of the research on INT was useful or a waste of time?
-
Q11.
Do you think that there was a difference in acceptance of INT in Europe vs. US?
-
Q12.
Why do you think the INT disappeared from mainstream immunology?
-
Q13.
What do you think now, do you think the INT was correct, wrong, or to some extent correct?
-
Q14.
What were the paradigms in immunology that superseded INT?
-
Q15.
There are still attempts at idiotypic approaches in clinical research, i.e. autoimmunity, cancer, vaccines.What are your views?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Chapter 14 References
Bona CA, Goldberg B, Rubinstein LJ (1984) Regulatory idiotopes, parallel sets and internal image of the antigen within the polyfructosan-A48 idiotypic network. Ann Immunol (Paris) 135C: 107–115
Hiernaux J, Bona C, Baker PJ (1981) Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med 153: 1004–1008
Fields BA, Goldbaum FA, Ysern X, Poljak RJ, Mariuzza RA (1995) Molecular basis of antigen mimicry by an anti-idiotope. Nature 374: 739–742
Oudin J, Cazenave PA (1971) Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function. Proc Nat Acad Sci USA 68: 2616
Jerne NK, Roland J, Cazenave PA (1982) Recurrent idiotopes and internal images. EMBO J 1: 243–247
Herzenberg LA, Chan EL, Ravitch MM, Riblet RJ, Herzenberg LA (1973) Active suppression of immunoglobulin allotype synthesis. 3. Identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow. J Exp Med 137: 1311–1324
Eichmann K, Coutinho A, Melchers F (1977) Absolute frequencies of lipopolysaccharide-reactive B cells producing A5A idiotype in unprimed, streptococcal A carbohydrate-primed, anti-A5A idiotype-sensitized and anti-A5A idiotype-suppressed A/J mice. J Exp Med 146: 1436–1449
Forni L, Coutinho A, Köhler G, Jerne NK (1980) IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci USA 77: 1125–1128
Coutinho A, Forni L, Holmberg D, Ivars F, Vaz N (1984) From an antigen-centered, clonal perspective of immune responses to an organism-centered, network perspective of autonomous activity in a self-referential immune system. Immunol Rev 79: 151–168
Varela FJ, Coutinho A (1991) Second generation immune networks. Immunol Today 12: 159–166
Germain RN, Benacerraf B (1980) Helper and suppressor T cell factors. Springer Semin Immunopathol 3: 93–127
Dietz MH, Sy MS, Benacerraf B, Nisonoff A, Greene MI, Germain RN (1981) Antigen-and receptor-driven regulatory mechanisms. VII. H-2-restricted antiidiotypic suppressor factor from efferent suppressor T cells. J Exp Med 153: 450–463
Germain RN (2008) Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology 123: 20–27
Cosenza H, Kohler H (1972) Specific suppression of the antibody response by antibodies to receptors. Proc Nat Acad Sci USA 69: 1701
Kluskens L, Köhler H (1974) Regulation of immune response by autogenous antibody against receptor. Proc Nat Acad Sci USA 71: 5083
Cosenza H (1976) Detection of anti-idiotype reactive cells in the response to phosphorylcholine. Eur J Immunol 6: 114–116
Bona C, Paul WE (1979) Cellular basis of regulation of expression of idiotype. I.T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med 149: 592–600
Gershon RK, Kondo K (1971) Infectious immunological tolerance. Immunology 21: 903–914
Hämmerling GJ, Black SJ, Berek C, Eichmann K, Rajewsky K (1976) Idiotypic analysis of lymphocytes in vitro. II. Genetic control of T-helper cell responsiveness to anti-idiotypic antibody. J Exp Med 143: 861–869
Joao C (2007) Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution. Med Hypotheses 68: 158–161
Eichmann K, Rajewsky K (1975) Induction of T and B cell immunity by antiidiotypic antibody. Eur J Immunol 5: 661–666
Krawinkel U, Cramer M, Imanishi-Kari T, Jack RS, Rajewsky K, Makela O (1977) Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon wool-enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol 7: 566–573
Eichmann K (1975) Idiotype suppression. II. Amplification of a suppressor T cell with anti-idiotypic activity. Eur J Immunol 5: 511–517
Sachs DH (1988) Anti-idiotype to MHC receptors — a possible route to specific transplantation tolerance? Int Rev Immunol 3: 313–321
Pisetsky DS, Sachs DH (1977) The genetic control of the immune response to staphylococcal nuclease VI. Recombination between genes determining the A/J anti-nuclease idiotypes and the heavy chain allotype locus. J Exp Med 146: 1603–1612
Binz H, Wigzell H, Bazin H (1976) T-cell idiotypes are linked to immunoglobulin heavy chain genes. Nature 264: 639–642
Green DR, Webb DR (1993) Saying the’ s’ word in public. Immunology Today 14: 523
Harvey MA, Adorini L, Miller A, Sercarz EE (1979) Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature 281: 594–596
Krzych U, Nanda N, Sercarz E (1989) Specificity and interactions of CD8+ T suppressor cells. Res Immunol 140: 302–307; discussion 339–345
Kumar V, Sercarz E (1993) T cell regulatory circuitry: antigen-specific and TCR-idiopeptide-specific T cell interactions in EAE. Int Rev Immunol 9: 287–297
Urbain J (1974) Cellular recognition and evolution. Arch Biol (Liege) 85: 139–150
Brait M, Vansanten G, Van Acker A, De Trez C, Luko CM, Wuilmart C, Leo O, Miller R, Riblet R, Urbain J (2002) In: M Zanetti and JD Capra (eds): Positive selection of B cell repertoire, idiotypic networks and immunological memory. The Antibodies Vol 7, Taylor and Francis. p1–27
João C, Ogle BM, Gay-Rabinstein C, Platt JL, Cascalho M. (2004) B celldependent TCR diversification. J Immunol 172: 4709–16
Goldner JA (1998) The unending saga of legal controls over scientific misconduct: A clash of cultures needing resolution. Am J Law Med 24: 293–343
Ismaili J, Brait M, Leo O, Urbain J (1995) Assessment of a functional role of auto-anti-idiotypes in idiotype dominance. Eur J Immunol 25: 830–837
Binz H, Wigzell H (1977) Antigen-binding, idiotypic receptors from T lymphocytes: an analysis of their biochemistry, genetics, and use as immunogens to produce specific immune tolerance. Cold Spring Harb Symp Quant Biol 41: 275–284
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag AG
About this chapter
Cite this chapter
(2008). Hindsight. In: The Network Collective. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8373-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8373-2_14
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8372-5
Online ISBN: 978-3-7643-8373-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)